You are here: Industry Insights > COVID-19 Vaccine

News List

Moderna applies for regulatory authorisation for COVID-19 vaccine europeanpharmaceuticalreview
December 03, 2020
The company has submitted for Emergency Use Authorization in the US and Conditional Marketing Authorization in Europe for its mRNA-1273 vaccine against COVID-19.
EMA initiates rolling review of Janssen’s Covid-19 vaccine candidate pharmaceutical-technology
December 03, 2020
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has initiated a rolling review of Janssen and Cilag International’s Covid-19 vaccine candidate, Ad26.COV2.S.
Pfizer-BioNTech COVID-19 vaccine gets EUA approval from the UK expresspharma
December 03, 2020
Care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable will be first in line.
Evaluating Pfizer vaccine for possible listing for emergency use: WHO expresspharma
December 03, 2020
WHO is in discussions with MHRA for accessing some of information from their assessment which may expedite WHO’s emergency listing.
DCGI finds no linkage between Covishield shot and volunteer’s adverse event during trial expresspharma
December 03, 2020
An expert committee recommended that compensation should not be paid to the subject or legal heir/nominee of the subject.
Pfizer-BioNTech can use UK as test bed for cold chain distribution: GlobalData expresspharma
December 03, 2020
The country’s small size, dense population and strong healthcare infrastructure should mean distribution of the vaccine with cold chain should go smoothly.
Survey finds 64 percent of UK adults would receive COVID-19 vaccine europeanpharmaceuticalreview
December 02, 2020
A survey of 1,500 adults in the UK showed that most would be happy to receive a COVID-19 vaccine, while nine percent said they would be unlikely to get the vaccine.
Pfizer, BioNTech Submit CMA for COVID-19 Vaccine americanpharmaceuticalreview
December 02, 2020
Pfizer and BioNTech have submitted a formal Application for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA) for their mRNA vaccine candidate, BNT162b2, against COVID-19.
UK secures total of 357 million doses of various COVID-19 vaccines europeanpharmaceuticalreview
December 01, 2020
After purchasing an additional two million doses of Moderna’s COVID-19 vaccine, the UK will now receive a total of 357 million doses of vaccines from seven developers.
Experts question continuation of Covishield vaccine trials in India despite adverse event report expresspharma
December 01, 2020
Censure SII’s move to file a defamation suit on the participant who reported the adverse event, stating that it will discourage honest feedback from participants and dissuade people from participating in clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page